Abstract:All-trans-retinoic acid (ATRA), the biologically most active metabolite of vitamin A, plays a major role in the regulation of cellular differentiation and proliferation, and it is also an important pharmacological agent particularly used in the treatment of cancer, skin, neurodegenerative and autoimmune diseases. However, ATRA is very easy to be metabolized into 4-hydroxyl-RA in vivo by CYP26A1, an inducible cytochrome P450 enzyme, eventually into more polar metabolites. Therefore, it is vital to develop specific retinoic acid metabolism blocking agents (RAMBAs) to inhibit the metabolic enzyme CYP26A1 in the treatment of relevant diseases aforementioned.In this study, CYP26A1 and its interactions with retinoic acid-competitive metabolism blocking agents were investigated by a combined ligand- and structure-based approach. First, since the crystal structure of CYP26A1 protein has not been determined, we constructed the 3D structure of CYP26A1 using homology modeling. In order to achieve a deeper insight into the mode of action of RAMBAs in the active site, the molecular superimposition model and the common feature pharmacophore model were constructed, and molecular docking was performed. The molecular superimposition model is composed of three features: the main chain groups, side chain groups, and azole groups. The common feature pharmacophore model consists of five chemical features: four hydrophobic groups and one hydrogen acceptor (HHHHA). The results of molecular docking show that the characteristic groups of RAMBAs were mapped into three different active pockets, respectively.A structure-activity relationship (SAR) was obtained by a combination of the molecular superimposition and docking results with the pharmacophore model. This study gives more insight into the interaction model inside the CYP26A1 active site and provides guidance for the design of more potent and possibly more selective RAMBAs. (C) 2014 Elsevier Inc. All rights reserved.

Meroterpenthiazole A, a unique meroterpenoid from the deep-sea-derived Penicillium allii-sativi, significantly inhibited retinoid X receptor (RXR)-α transcriptional effect

Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor

Rexinoid Inhibits Nrf2-Mediated Transcription Through Retinoid X Receptor Alpha

Molecular Recognition of CYP26A1 Binding Pockets and Structure–activity Relationship Studies for Design of Potent and Selective Retinoic Acid Metabolism Blocking Agents

Bexarotene: a Promising Anticancer Agent

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Chemical Constituents from the Deep Sea-Derived Streptomyces Xiamenensis MCCC 1A01570 and Their Effects on RXRα Transcriptional Regulation.

Steroids From The Deep-Sea-Derived Fungus Penicillium Granulatum Mccc 3a00475 Induced Apoptosis Via Retinoid X Receptor (Rxr)-Alpha Pathway

Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties

Derivation of a Retinoid X Receptor Scaffold from Peroxisome Proliferator‐Activated Receptor Γ Ligand 1‐Di(1h‐indol‐3‐yl)methyl‐4‐trifluoromethylbenzene

Structure-guided design of a highly potent RXR agonist with superior physicochemical properties

Novel Bioactive Penicipyrroether A and Pyrrospirone J from the Marine-Derived Penicillium Sp. ZZ380.

Facile constructed meroterpenoids with novel hexadecahydroacephenanthrylene carbon skeleton using the biotransformation and chemical synthesis method

Structural basis for the full and partial agonist activities of retinoid X receptor α ligands with an iso-butoxy and an isopropyl group

Meroterpenoids from the marine-derived fungus Aspergillus terreus GZU-31-1 exerts anti-liver fibrosis effects by targeting the Nrf2 signaling in vitro

Rhodomentones A and B, Novel Meroterpenoids with Unique NMR Characteristics from Rhodomyrtus Tomentosa.

Discovery of novel triazine derivatives as potent retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonists

Isolation of a new meroterpene and inhibitors of nitric oxide production from Psoralea corylifolia fruits guided by TLC bioautography

Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics

Lipid-Lowering Meroterpenoids Penihemeroterpenoids A-F from Penicillium herquei GZU-31-6 via Targeting the AMPK/ACC/SREBP-1c Signaling Pathway

Meroterpenoids with divers' rings systems from Phyllosticta capitalensis and their anti-inflammatory activity